Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5824717 | Clinical Therapeutics | 2015 | 13 Pages |
Abstract
Incorporating a comparative evaluation of statins in Qatari practices based on a locally developed, transparent, multi-indication, multi-criteria scoring model has the potential to considerably reduce expenditures on statins. Atorvastatin and pravastatin should be the first-line statin therapies in the main Qatari health care provider, with rosuvastatin as an alternative.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Daoud PhD, Michael PhD, Ibrahim PhD, Abdullatif MD, Manal PharmD,